EN DE
Watch Nonthavej Hospital Public Company Limited for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Nonthavej Hospital Public Company Limited (NTV) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Nonthavej Hospital Public Company Limited stock THB 28.23, price THB 18.70, upside +51.0%, quality 61 out of 100. Rating: strongly undervalued. Calculated from audited financials with 25 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare TH · ISIN TH0421010Z08

NH Nonthavej Hospital Public Company Limited logo Thin data Nov 9, 2026

Nonthavej Hospital Public Company Limited

NTV · BK
Undervalued, but in a downtrend

The stock costs 34% less than our calculation considers fair.

Fair value 28.23 THB · Strongly undervalued
Quality 61/100
Generates free cash flow
5.6% dividend yield · Sustainable
Ranks above peers (11/13)
Even on cautious assumptions the value is 12% above the price (20.87 THB).
Mixed Growth (revenue 5y +4.8 %/yr in THB)
Thin margins · 9.8% net margin (TTM)
Moderate moat 48/100 · thin data
Thin data
Watch Nonthavej Hospital Public Company Limited for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

38.57 THB 18.40 THB Fair Value 28.23 THB May 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 9, 2026.

How to read this chart

60‑month range 18.40 THB – 38.57 THB · fair‑value band 20.87 THB – 36.88 THB · the 18.70 THB price screens below the 28.23 THB fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 9, 2026.

Follow Nonthavej Hospital Public Company in your weekly email

Every Wednesday you see whether Nonthavej Hospital Public Company is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Nonthavej Hospital Public Company Limited engages in the business of medical treatment in Thailand. The company provides medical services for inpatients and outpatients, as well as emergency cases with 24-hour ambulance service.

Show moreShow less

It operates specialized medical centers and clinics that offer services in the areas of laparoscope surgery, breast cancer, children and teens, neurology, dental, diabetes, diagnostic digital imaging, emergency, gastrointestinal system and liver, general medicine, gynecologic cancer treatment, gynecologic laparoscopic surgery and gynecologic cancer, gynecological, hemodialysis, ICU and CCU, minimally invasive surgery, nephrology, operations, orthopedics, pain clinic, physical medicine and rehabilitation, pregnancy, respiration, skin and cosmetic surgery, sleep lab, vascular, and wellness, as well as eye, ear, nose, and throat.

In addition, the company provides health checkup, ambulatory, and ward facility services. Nonthavej Hospital Public Company Limited was founded in 1981 and is headquartered in Nonthaburi, Thailand.

Stock analysis

Nonthavej Hospital Public Company Limited (NTV) currently trades at 18.70 THB, while our model-based Fair Value estimate is 28.23 THB, implying the stock looks roughly 34% undervalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of 38.96 THB per share, and 19 of the 25 models we run sit above the 18.70 THB price.

Bear case: the Asset-Based group reads lowest at 7.72 THB, and 6 of the 25 models stay below the price. Data coverage for this calculation is low.

Scenario range: 20.87 THB (bear) to 36.88 THB (bull), the price of 18.70 THB sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 61/100 (solid quality), in the Healthcare sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Nonthavej Hospital Public Company Limited reported revenue of 2.4B THB in FY2025 versus 1.8B THB in FY2021, a compound +7.4%/yr. Reported net income was 277M THB in FY2025, compounding +14.8%/yr from FY2021.

Key figures

Market cap 3.0B THB (≈ $89.4M) Micro · P/E ratio 13.3 · P/S ratio 1.30 · EPS (TTM) 1.41 THB · Dividend yield 5.6% · Net margin 9.8% · Return on equity 8.4% · Return on assets (EBIT) 12.1% (5-year average).

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 48 out of 100 (low confidence).

What moves the price

The share trades about 20% below its 52-week high and 2% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −1% fair-value upside, at 51%, NTV screens cheaper than that median.

Fair Value models

Bear 20.87 THB Fair Value 28.23 THB Bull 36.88 THB
Price 18.70 THB · Upside +51.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (0.3173 THB per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF 16.73 THB 19.66 THB 23.03 THB 80
Growth DCF 16.81 THB 19.42 THB 22.29 THB 77
Residual Income 13.84 THB 14.77 THB 16.32 THB 76
All 25 models by family
DCF Models
FCF DCF 16.73 THB 19.66 THB 23.03 THB 80
Owner Earnings 16.87 THB 19.85 THB 23.27 THB 75
5Y Revenue Exit 20.32 THB 27.71 THB 36.88 THB 71
5Y EBITDA Exit 27.22 THB 40.08 THB 54.59 THB 73
5Y P/E Exit 24.84 THB 35.81 THB 46.85 THB 69
10Y Revenue Exit 18.14 THB 23.65 THB 30.56 THB 65
10Y EBITDA Exit 22.12 THB 30.65 THB 41.37 THB 66
10Y P/E Exit 20.87 THB 28.23 THB 36.65 THB 62
Earnings-Based
Graham-Dodd 11.76 THB 29.19 THB 37.84 THB 65
PEG = 1.0 5.30 THB 7.58 THB 9.85 THB 57
EPV 17.30 THB 18.49 THB 19.44 THB 70
Dividend Discount
Gordon GGM 9.18 THB 14.03 THB 18.39 THB 69
DDM Multi-Stage 9.18 THB 12.53 THB 15.38 THB 67
Multiples
P/E Multiple 28.54 THB 38.05 THB 47.57 THB 63
P/S Multiple 22.05 THB 29.41 THB 36.76 THB 58
P/B Multiple 38.56 THB 51.41 THB 64.26 THB 55
EV/EBIT 31.64 THB 39.87 THB 48.10 THB 63
EV/EBITDA 40.57 THB 51.78 THB 62.98 THB 64
EV/Revenue 24.57 THB 32.12 THB 39.68 THB 52
Asset-Based
NCAV (Graham) 5.09 THB 7.72 THB 9.65 THB 52
Growth DCF
Growth DCF 16.81 THB 19.42 THB 22.29 THB 77
Rev-Margin DCF 20.32 THB 27.79 THB 35.86 THB 71
Economic Profit
Residual Income 13.84 THB 14.77 THB 16.32 THB 76
ROIC Compounder 17.30 THB 18.71 THB 20.16 THB 70
Growth Earnings
Growth-Adj P/E 21.87 THB 31.24 THB 40.62 THB 67

Open the full fair value analysis →

Quality Score breakdown

Overall quality 61/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 49
How much profit the company makes from its sales and capital
Quality Growth 17
Are margins and returns getting better?
Cashflow 51
Do the profits arrive as real cash?
Financial strength 99
Debt, balance sheet and risk of trouble
Investment 69
Does it invest with discipline instead of growing at any price?
Low Volatility 99
How calm the share price moves, does not count
Price momentum 26
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 8
Distance to the 52-week high, does not count
New shares 82
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 62/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−4.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+1.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.8%
Start year 2020 (pandemic). Over 10 years: +2.2% a year
Revenue growth 25 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.2%
What shareholders gained per year (last 5 years), in THB ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in THB: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+9.3%
Earnings growth per share plus dividend.
Earnings per share, growth per year+3.7%
Dividend (yield on the price)5.6%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.3.7% vs −0.7%, picking up
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.15% → 13%
Pace: the 5-year rate starts in 2020 (pandemic)

Growth Forecast

Price in line with expectations
The price assumes about as much growth as the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+2.3%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Thailand: IMF forecast 1.2% a year to 2030, 1.1% from 2016 to 2025) that is about +1.0% a year for the price.

Watch NTV, get fair value alerts →

Compare Nonthavej Hospital Public Company Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 234 stocks

Beats the industry median on 11/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 61 · Above median
Fair Value upside +51.0% · Top 25%
Profitability
Return on equity (12 months) 8.4% · Above median
Return on assets 8.7% · Top 25%
Net margin (12 months) 9.8% · Above median
Operating margin (12 months) 8.1% · Below median
Growth and dividend
Revenue growth (quarter YoY) −6.0% · Bottom 25%
Dividend yield (12 months) 5.6% · Top 25%

Valuation Multiplesvs Medical Care Facilities median · lower = cheaper

P/E (12 months) 13.3× · Cheapest 25%
P/B 1.06× · Cheapest 25%
P/S (12 months) 1.30× · Cheaper than median
Price / free cash flow (fiscal year) 14.8× · Cheaper than median
EV/EBITDA 4.1× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 34
FUTURE (revenue growth)0 · sector 31
PAST (return on equity)33 · sector 32
HEALTH (low debt)0 · sector 90
DIVIDEND (yield)100 · sector 39

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Fresenius Medical Care AG FMS $23.40 $46.55 +99% vs NTV
Aier Eye Hospital Group 300015 ¥9.01 ¥10.88 +21% vs NTV
DaVita Inc DVA $191.35 $218.90 +14% vs NTV
HCA Healthcare, Inc HCA $494.99 $547.34 +11% vs NTV
Tenet Healthcare Corporation THC $283.33 $279.20 −1% vs NTV
The Ensign Group ENSG $181.08 $140.09 −23% vs NTV
Encompass Health Corporation EHC $137.54 $94.81 −31% vs NTV
Fresenius SE FRE €52.48 €34.77 −34% vs NTV
Apollo Hospitals Enterprise Limited APOLLOHOSP ₹8,446 ₹5,234 −38% vs NTV
Dr. Sulaiman Al Habib Medical Services Group 4013 215.00 SAR 109.45 SAR −49% vs NTV

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Nonthavej Hospital Public Company Limited: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Nonthavej Hospital Public Company Limited Fair Value". https://www.fairvalue-calculator.com/stock/NTV

Frequently asked questions

Is Nonthavej Hospital Public Company Limited (NTV) overvalued or undervalued?
As of Nov 9, 2026, our model estimates a fair value of 28.23 THB versus a price of 18.70 THB, about +51% upside (undervalued).
What is the fair value of NTV?
Our model-based fair value for Nonthavej Hospital Public Company Limited is 28.23 THB (as of Nov 9, 2026), built from audited fundamentals. The current price: 18.70 THB.
What is the quality score of NTV?
Nonthavej Hospital Public Company Limited has a Quality Score of 61/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Nonthavej Hospital Public Company Limited (NTV)?
Our model-based price target is the fair value of 28.23 THB (as of Nov 9, 2026) from 25 valuation models. Cautious scenario 20.87 THB, optimistic scenario 36.88 THB. It is a calculation from audited fundamentals, not an analyst target.
What is the Nonthavej Hospital Public Company Limited stock forecast for 2026?
Our models put fair value at 28.23 THB, about +51% upside versus a price of 18.70 THB (undervalued). Cautious scenario 20.87 THB, optimistic scenario 36.88 THB. The calculation is refreshed regularly with new filings.
What is the revenue of Nonthavej Hospital Public Company Limited (NTV)?
Nonthavej Hospital Public Company Limited reported trailing-twelve-month revenue of about 2.3B THB (latest available figure, as of Nov 9, 2026).
Does Nonthavej Hospital Public Company Limited pay a dividend?
Nonthavej Hospital Public Company Limited currently shows a dividend yield of 5.56% relative to its recent price (as of Nov 9, 2026).
How much is the dividend of Nonthavej Hospital Public Company Limited (NTV) and when is the ex-dividend date?
Nonthavej Hospital Public Company Limited pays a dividend of 1.04 THB per share a year, a dividend yield of 5.6%. The last ex-dividend date was Mar 19, 2026. A dividend has been paid every year since at least 1996. The payout ratio is 73.8% of earnings. Free cash flow covers the dividend 1.22 times. Our assessment: Sustainable. Payout and cash coverage both look sustainable.
What growth is priced into Nonthavej Hospital Public Company Limited (NTV)?
For today's price to be fair in a discounted-cash-flow model, Nonthavej Hospital Public Company Limited would have to grow free cash flow by +2.3 % per year for five years (discount rate 13.1 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +4.8 % per year. As of Nov 9, 2026.
What discount rate (WACC) does the fair value of NTV use?
Our models discount Nonthavej Hospital Public Company Limited at 13.1 %: a base by market capitalisation (micro), damped by beta 0.12, country premium for Thailand. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Nonthavej Hospital Public Company Limited that is +2.3 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (13.1 %) and the same formula as our fair value.
How much growth has Nonthavej Hospital Public Company Limited (NTV) delivered so far?
Over the past 5 years revenue at Nonthavej Hospital Public Company Limited grew +4.8 % a year. The price currently implies free-cash-flow growth of +2.3 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Nonthavej Hospital Public Company Limited (NTV) growing?
The median revenue growth in the sector is +6.2 % a year. That is the yardstick for the growth priced into Nonthavej Hospital Public Company Limited (+2.3 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Nonthavej Hospital Public Company Limited (NTV)?
The free-cash-flow yield on the price is 6.77 %: that much free cash flow Nonthavej Hospital Public Company Limited produces per unit of market value. When it exceeds the discount rate of our models (13.1 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Nonthavej Hospital Public Company Limited (NTV)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Nonthavej Hospital Public Company Limited it is 28.23 THB per share (as of Nov 9, 2026), against a price of 18.70 THB. It is the blended result of 25 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Nonthavej Hospital Public Company Limited stock overvalued or undervalued in 2026?
As of Nov 9, 2026, NTV trades below its calculated fair value: price 18.70 THB, fair value 28.23 THB, a gap of about +51% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of NTV?
No. The price is what the market pays today (18.70 THB); the fair value is what the company's own numbers justify (28.23 THB). For Nonthavej Hospital Public Company Limited the two are 9.53 THB per share apart. That gap is exactly why we show both numbers side by side.
How much is Nonthavej Hospital Public Company Limited worth?
The market values Nonthavej Hospital Public Company Limited at about 3.0B THB (market capitalisation, as of Nov 9, 2026). Per share that is 18.70 THB; our models calculate a fair value of 28.23 THB per share.
What do the bullish and bearish scenarios say about NTV?
Our models span a range for Nonthavej Hospital Public Company Limited: cautious scenario 20.87 THB, base 28.23 THB, optimistic 36.88 THB per share (as of Nov 9, 2026, price 18.70 THB). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of NTV?
Nonthavej Hospital Public Company Limited trades at a price-to-earnings ratio of 13.3 (as of Nov 9, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 28.23 THB is built from several models across several years. Median P/E at fiscal year-end, 10 fiscal years (2016 to 2025), reported earnings: 22.0. Other multiples: P/B 1.1, P/S 1.3, EV/EBITDA 4.1.
How solid is the balance sheet of Nonthavej Hospital Public Company Limited (NTV)?
Balance-sheet figures for Nonthavej Hospital Public Company Limited (as of Nov 9, 2026): return on equity 8.4%. They feed the Quality Score of 61/100, which measures business quality independently of the share price.
How far is NTV from its 52-week high?
Nonthavej Hospital Public Company Limited trades at 18.70 THB, about 20% below its 52-week high of 23.50 THB and 2% above the low of 18.40 THB (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 28.23 THB is for.
Which stocks are comparable to Nonthavej Hospital Public Company Limited?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Tenet Healthcare Corporation, Dr. Sulaiman Al Habib Medical Services Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Nonthavej Hospital Public Company Limited stock attractive at the current price?
The data as of Nov 9, 2026: price 18.70 THB, calculated fair value 28.23 THB (+51%), Quality Score 61/100, from 25 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of NTV calculated?
We run Nonthavej Hospital Public Company Limited through 25 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 28.23 THB builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Nonthavej Hospital Public Company Limited currently trades 34% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Nonthavej Hospital Public Company Limited (NTV)?
The closing price on Nov 6, 2026 was 18.70 THB. Our model-based fair value is 28.23 THB, about +51% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Nonthavej Hospital Public Company Limited right now?
The price is below even our cautious bear case (20.87 THB). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (61/100) at a price below fair value, the discount is the argument here, not the business quality.
Where does the earnings growth of Nonthavej Hospital Public Company Limited (NTV) come from?
Earnings per share at Nonthavej Hospital Public Company Limited grew +1.7 % a year from 2014 to 2025. Broken into its drivers: revenue per share +2.7 %, EBIT margin −1.6 %, tax rate −0.1 %, residual (interest, one-offs) +0.7 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Nonthavej Hospital Public Company Limited

How large is the market capitalisation of Nonthavej Hospital Public Company Limited (NTV)?
The market capitalisation of Nonthavej Hospital Public Company Limited is 3.0B THB (≈ $89.4M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Nonthavej Hospital Public Company Limited (NTV)?
The price-to-sales ratio of Nonthavej Hospital Public Company Limited is 1.30 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Nonthavej Hospital Public Company Limited (NTV)?
Earnings per share at Nonthavej Hospital Public Company Limited are 1.41 THB (price ÷ EPS = P/E 13.3). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Nonthavej Hospital Public Company Limited (NTV)?
The dividend yield of Nonthavej Hospital Public Company Limited is 5.6% (payout 73.8%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Nonthavej Hospital Public Company Limited (NTV)?
The net margin of Nonthavej Hospital Public Company Limited is 9.8% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Nonthavej Hospital Public Company Limited (NTV)?
The return on equity (ROE) of Nonthavej Hospital Public Company Limited is 8.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Nonthavej Hospital Public Company Limited (NTV)?
On an EBIT basis the return on assets of Nonthavej Hospital Public Company Limited is 12.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Nonthavej Hospital Public Company Limited (NTV)?
The operating margin of Nonthavej Hospital Public Company Limited is 8.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Nonthavej Hospital Public Company Limited (NTV)?
Revenue at Nonthavej Hospital Public Company Limited is growing −6.0% versus a year earlier (3y avg +1.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Nonthavej Hospital Public Company Limited (NTV)?
Earnings per share at Nonthavej Hospital Public Company Limited are growing −32.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Nonthavej Hospital Public Company Limited (NTV) hold?
Nonthavej Hospital Public Company Limited holds more cash than debt, 1.1B THB net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Nonthavej Hospital Public Company Limited in the live analysis

One click puts Nonthavej Hospital Public Company Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.